Omeros (OMER) Operating Margin (2010 - 2026)
Omeros recorded quarterly Operating Margin of 176.09% in Q1 2026, down 32.66% quarter-over-quarter from 132.74% in Q3 2021.
Omeros' Operating Margin history runs 13 years deep, the most recent figure standing at 176.09% for Q1 2026.
- In Q1 2026, Operating Margin changed N/A year-over-year to 176.09%; the TTM figure through Mar 2026 stood at 153.15% (up 5074.0% YoY), while the FY2020 annual figure was 212.59%, down 8197.0% from the prior year.
- Operating Margin came in at 176.09% for Q1 2026 at Omeros, down from 132.74% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 176.09% in Q1 2026 to a low of 176.09% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -176.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -176.09% |
| Sep 30, 2021 | -132.74% |
| Jun 30, 2021 | -158.24% |
| Mar 31, 2021 | -215.04% |
| Dec 31, 2020 | -318.06% |
| Sep 30, 2020 | -97.37% |
| Jun 30, 2020 | -204.58% |
| Mar 31, 2020 | -100.59% |
| Dec 31, 2019 | -70.93% |
| Sep 30, 2019 | -37.18% |
| Jun 30, 2019 | -34.90% |
| Mar 31, 2019 | -88.34% |
| Dec 31, 2018 | -83.91% |
| Sep 30, 2018 | -769.14% |
| Jun 30, 2018 | -1,849.97% |
| Mar 31, 2018 | -1,743.64% |
| Dec 31, 2017 | -102.62% |
| Sep 30, 2017 | -23.59% |
| Jun 30, 2017 | -69.61% |
| Mar 31, 2017 | -103.82% |
| Dec 31, 2016 | -91.88% |
| Sep 30, 2016 | -106.63% |
| Jun 30, 2016 | -109.25% |
| Mar 31, 2016 | -262.19% |
| Dec 31, 2015 | -270.26% |
| Sep 30, 2015 | -592.24% |
| Jun 30, 2015 | -501.00% |
| Mar 31, 2015 | -4,621.13% |
| Dec 31, 2014 | -11,097.22% |
| Sep 30, 2014 | -8,005.61% |
| Jun 30, 2014 | -38,260.00% |
| Mar 31, 2014 | -15,684.00% |
| Dec 31, 2013 | -8,226.04% |
| Sep 30, 2013 | -6,854.08% |
| Jun 30, 2013 | -9,400.00% |
| Mar 31, 2013 | -915.07% |
| Dec 31, 2012 | -475.87% |
| Sep 30, 2012 | -919.97% |
| Jun 30, 2012 | -540.24% |
| Mar 31, 2012 | -539.57% |
| Dec 31, 2011 | -861.50% |
| Sep 30, 2011 | -624.52% |
| Jun 30, 2011 | -428.48% |
| Mar 31, 2011 | -520.58% |
| Dec 31, 2010 | -876.74% |
| Sep 30, 2010 | -2,948.82% |
| Jun 30, 2010 | -1,536.02% |